Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier BV in Lung Cancer
- Vol. 46 (3), 361-368
- https://doi.org/10.1016/j.lungcan.2004.05.009